Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01072539

Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment

Complicated Intra-abdominal Infections Clinical Trial

Official title:
A Post-marketing Surveillance (Pms) Study Of Safety And Effectiveness In Patients With Tigecycline Treatment

Clinical Trial Summary

The primary objective of this study is to identify any changes on the safety profile of adverse events and serious adverse events. And the secondary objective is to evaluate clinical response in the clinically evaluable population at test-of cure (TOC) or at the end of treatment (EOT) assessment, and microbiologic response at the subject level, if available.

Clinical Trial Description

Prior to the conduct of this study, the investigator will explain the study objective, etc to prospective subjects on the basis of "explanatory material." The informed consent will be obtained in written form by each subject voluntarily. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01072539
Study type Observational
Source Pfizer
Contact
Status Completed
Phase
Start date May 2010
Completion date April 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT00389987 - Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037) Phase 3
Completed NCT02784704 - Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections Phase 3
Completed NCT00752219 - Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections Phase 2
Completed NCT03830333 - Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015) Phase 3
Not yet recruiting NCT03678298 - Italian Register for the Study of Complicated Intra-Abdominal Infections
Active, not recruiting NCT00860587 - Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections N/A
Completed NCT01844856 - Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections Phase 3
Completed NCT02475733 - Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs). Phase 2
Completed NCT00683332 - Post-Marketing Study Of The Safety Of Tygacil (Tigecycline) N/A